Delirium, Dementia, Amnestic, Cognitive Disorders  >>  PF-05212377  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
PF-05212377 / Pfizer
NCT01712074 / 2014-000830-42: Study Evaluating TheSafety And Efficacy Of PF-05212377 Or Placebo In Subjects With Alzheimer's Disease With Existing Neuropsychiatric Symptoms On Donepezil

Terminated
2
186
US, Canada, Europe, RoW
PF-05212377 (SAM-760), Placebo
Pfizer
Alzheimer's Disease
09/15
09/15

Download Options